Medications

US drugs firm Mylan completes $1.75 bln India buyout

US generic drug specialist Mylan said Thursday it had completed its $1.75 billion acquisition of a unit of India's Strides Arcolab, boosting its presence in the high-growth injectable drugs market.

Medications

Shares of India's Ranbaxy slide 19% on new US FDA ban

Shares in one of India's biggest drugmakers, Ranbaxy Laboratories, slid 19 percent Friday after the US Food and Drug Administration suspended imports from a fourth manufacturing plant of the firm.

Other

Indian drug giant Dr Reddy's Q2 profit up 69%

India's second-largest drugmaker Dr Reddy's Laboratories on Tuesday reported a 69.4 percent jump in quarterly net profit, as profit margins rose helped by improved sales.

Diseases, Conditions, Syndromes

Fall in new cases raises hope in virus outbreak in China

The number of new cases of the coronavirus in China dropped for a second straight day, health officials said Wednesday in a possible glimmer of hope amid the outbreak that has infected over 45,000 people worldwide and killed ...

page 4 from 4